Loading clinical trials...
Loading clinical trials...
ACT on Vaping: Digital Therapeutic for Young Adult Vaping Cessation
This clinical trial evaluates a smartphone application (app) called Acceptance and Commitment Therapy (ACT) on Vaping for helping young adults quit using electronic cigarettes (e-cigarettes). E-cigarettes pose numerous risks, particularly to youth and young adults. Addressing the high prevalence of e-cigarette use by young adults requires effective and accessible treatments to support current users to quit. Research shows this group prefers and benefits from newer methods of treatment delivery such as digital interventions. ACT on Vaping is a digital therapeutic intended to deliver behavioral therapy to young adults who vape to motivate and support abstinence from all nicotine and tobacco products. The app contains sessions that promote awareness of cues that trigger tobacco use and teach skills for responding to these triggers in a way that is tailored for the participant's readiness to quit. Receiving access to the ACT on Vaping app may be effective in helping young adults quit vaping.
OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants use the ACT on Vaping app (Version A) and receive a text messaging program to motivate and support quitting. Participants also receive incentivized text message check-ins at 2 weeks, 2 months, and 4 months to assess their vaping status. ARM II: Participants use the ACT on Vaping app (Version B) and receive incentivized text message check-ins at 2 weeks, 2 months, and 4 months to assess their vaping status. After completion of study intervention, participants are followed up at 3 and 6 months.
Age
18 - 30 years
Sex
ALL
Healthy Volunteers
Yes
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Start Date
March 30, 2026
Primary Completion Date
October 31, 2027
Completion Date
October 31, 2027
Last Updated
March 12, 2026
1,372
ESTIMATED participants
Smartphone app
BEHAVIORAL
Smartphone app
BEHAVIORAL
Text Message
OTHER
Text Message
OTHER
Survey Administration
OTHER
Lead Sponsor
Fred Hutchinson Cancer Center
Collaborators
NCT01036581
NCT06249984
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06765291